(Q44193506)

30 November 2017

title

A phase 1 study of the cholecystokinin (CCK) B antagonist L-365,260 in human subjects taking morphine for intractable non-cancer pain (English)

1 reference

human subject research project

30 November 2017

main subject

0 references

1 reference

Gary J McCleane

1

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

332

1 reference

30 November 2017

issue

3

1 reference

30 November 2017

page(s)

210-212

1 reference

Spinal effect of the cholecystokinin-B receptor antagonist CI-988 on hyperalgesia, allodynia and morphine-induced analgesia in diabetic and mononeuropathic rats

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900934-5

7 January 2021

Increases of CCK mRNA and peptide in different brain areas following acute and chronic administration of morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900934-5

7 January 2021

Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364,718.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900934-5

7 January 2021

The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900934-5

7 January 2021

Evidence for the Neuropeptide Cholecystokinin as an Antagonist of Opiate Analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900934-5

7 January 2021

Distinct cholecystokinin receptors in brain and pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900934-5

7 January 2021

Localization and molecular heterogeneity of cholecystokinin in the central and peripheral nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900934-5

7 January 2021

The CCK-A and CCK-B receptor antagonists, devazepide and L-365,260, enhance morphine antinociception only in non-acclimated rats exposed to a novel environment

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900934-5

7 January 2021

Dissociation of tolerance and dependence to morphine: a possible role for cholecystokinin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900934-5

7 January 2021

Association of enkephalin catabolism inhibitors and CCK-B antagonists: a potential use in the management of pain and opioid addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900934-5

7 January 2021

Cholecystokinin inhibits peripheral opioid analgesia in inflamed tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900934-5

7 January 2021

Proglumide prevents and curtails acute tolerance to morphine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900934-5

7 January 2021

Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900934-5

7 January 2021

Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900934-5

7 January 2021

CCK antagonists: pharmacology and therapeutic interest

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900934-5

7 January 2021

The role of cholecystokinin in nociception, neuropathic pain and opiate tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900934-5

7 January 2021

PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900934-5

7 January 2021

Increased level of cholecystokinin in cerebrospinal fluid is associated with chronic pain-like behavior in spinally injured rats

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900934-5

7 January 2021

Up-regulation of cholecystokinin in primary sensory neurons is associated with morphine insensitivity in experimental neuropathic pain in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900934-5

7 January 2021

Cholecystokinin receptor mechanism(s) and morphine tolerance in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900934-5

7 January 2021

Effects of caerulein and CCK antagonists on tolerance induced to morphine antinociception in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900934-5

7 January 2021

10.1016/S0304-3940(02)00934-5

Identifiers

DOI

1 reference

30 November 2017

1 reference